Lonza Launches Xcite AAV Producer Cell Line Platform

Endpoints NewsEU reaches provisional deal on Critical Medicines Act

Endpoints NewsFDA Commissioner Makary to resign, source says

Endpoints NewsIran war disruptions begin to emerge upstream of the pharma supply chain

FierceBiotechCharles River debuts AI diagnostic tool to cut down pathology timelines

10x Genomics NewsThis $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116% - The Motley Fool

Endpoints NewsWhat I learned at a journalism fellowship about covering healthcare AI

BioPharma DiveArvinas, Pfizer find new partner for ‘Protac’ breast cancer drug

FierceBiotechAlphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model

BioWorldOther news to note for May 12, 2026

Endpoints NewsFive burning Qs for Isomorphic Labs after $2.1B raise for AI biotech

Lonza NewsLonza Launches Xcite AAV Producer Cell Line Platform - Contract Pharma

Endpoints NewsPfizer and Arvinas give disappointing breast cancer drug to Rigel